NCT03314493View on ClinicalTrials.gov

Prevention of the Progression of Coronary Calcification With Use of Spironolactone in Peritoneal Dialysis Patients

PHASE3CompletedINTERVENTIONAL
Enrollment

33

Participants

Timeline

Start Date

November 7, 2014

Primary Completion Date

November 10, 2016

Study Completion Date

November 10, 2016

Conditions
Coronary Artery CalcificationVascular Calcification
Interventions
DRUG

Spironolactone 25Mg Tablet

Patients with coronary calcium score \> 30 were treated with spironolactone for 12 months

Trial Locations (1)

50070-550

Instituto de Medicina Integral Prof. Fernando Figueira, Recife

All Listed Sponsors
collaborator

Federal University of São Paulo

OTHER

lead

Professor Fernando Figueira Integral Medicine Institute

OTHER

NCT03314493 - Prevention of the Progression of Coronary Calcification With Use of Spironolactone in Peritoneal Dialysis Patients | Biotech Hunter | Biotech Hunter